ZA936137B - Method of treatment of reversible obstructive airways diseases - Google Patents

Method of treatment of reversible obstructive airways diseases

Info

Publication number
ZA936137B
ZA936137B ZA936137A ZA936137A ZA936137B ZA 936137 B ZA936137 B ZA 936137B ZA 936137 A ZA936137 A ZA 936137A ZA 936137 A ZA936137 A ZA 936137A ZA 936137 B ZA936137 B ZA 936137B
Authority
ZA
South Africa
Prior art keywords
treatment
obstructive airways
airways diseases
reversible obstructive
reversible
Prior art date
Application number
ZA936137A
Other languages
English (en)
Inventor
Catherine Hallam
Stephen Thomas Harper
Original Assignee
Fisions Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisions Plc filed Critical Fisions Plc
Publication of ZA936137B publication Critical patent/ZA936137B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA936137A 1992-08-25 1993-08-20 Method of treatment of reversible obstructive airways diseases ZA936137B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929218027A GB9218027D0 (en) 1992-08-25 1992-08-25 Novel method of treatment

Publications (1)

Publication Number Publication Date
ZA936137B true ZA936137B (en) 1994-02-21

Family

ID=10720906

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA936137A ZA936137B (en) 1992-08-25 1993-08-20 Method of treatment of reversible obstructive airways diseases

Country Status (6)

Country Link
AU (1) AU4967193A (xx)
GB (1) GB9218027D0 (xx)
IL (1) IL106751A0 (xx)
MX (1) MX9305152A (xx)
WO (1) WO1994004148A1 (xx)
ZA (1) ZA936137B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP223198A0 (en) * 1998-03-06 1998-04-02 Fujisawa Pharmaceutical Co., Ltd. New use
GB9917158D0 (en) * 1999-07-21 1999-09-22 Fujisawa Pharmaceutical Co New use
PT1666028E (pt) 1999-10-29 2010-06-15 Novartis Ag Composições de pós anidros com melhor dispersividade
US6878751B1 (en) * 2000-10-19 2005-04-12 Imperial College Of Science Technology And Medicine Administration of resveratrol to treat inflammatory respiratory disorders
AR035411A1 (es) * 2000-12-29 2004-05-26 Fujisawa Pharmaceutical Co Uso de un derivado de tacrolimus para fabricar un agente neurotrofico, composiciones y articulos de fabricacion o kits que lo comprenden, metodo para fabricar un agente que lo comprende y tejidos e injertos con una celula nerviosa tratada con este compuesto
JP2007518692A (ja) * 2004-01-20 2007-07-12 アステラス製薬株式会社 勃起不全治療方法
MX2019005504A (es) 2016-11-10 2019-08-12 Novartis Ag Potenciadores de bmp.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU630866B2 (en) * 1987-12-09 1992-11-12 Fisons Plc Macrocyclic compounds
IE64214B1 (en) * 1989-06-06 1995-07-26 Fujisawa Pharmaceutical Co Macrolides for the treatment of reversible obstructive airways diseases
GR1001225B (el) * 1989-09-14 1993-06-30 Fisons Plc Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους.
CA2054983A1 (en) * 1990-11-08 1992-05-09 Sotoo Asakura Suspendible composition and process for preparing the same

Also Published As

Publication number Publication date
WO1994004148A1 (en) 1994-03-03
GB9218027D0 (en) 1992-10-14
AU4967193A (en) 1994-03-15
MX9305152A (es) 1994-05-31
IL106751A0 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
AU3067995A (en) Method for treatment of sleep apnea
HU9302875D0 (en) Method for producing carboxyc acid derivatives and medical preparatives containing them
EP0421946A3 (en) 3-indolepyruvic acid derivatives their method of production and therapeutic use
AU7682991A (en) Heat controller and method for heat treatment of metal
AU8910891A (en) Treatment of lung diseases
IL115015A0 (en) Methods of inhibiting demyelinating and desmyelinating diseases
AU5960394A (en) Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases
PL309600A1 (en) Pharmaceutical compositions for preventing and treating neoplastic diseases and method of obtaining them
HU9402709D0 (en) Pentofixillin for producing pharmaceutical compositions for treating lung diseases of granuloma and fibrozis
ZA936137B (en) Method of treatment of reversible obstructive airways diseases
EP0460480A3 (en) Bacterin for the treatment of necrophorum diseases and a method for the production thereof
ZA932303B (en) Medicament for the treatment of airways inflammation and airways hyperresponsiveness
GB9202196D0 (en) Method of treatment
AU2992295A (en) Therapeutic method and compounds of use therein
AU6097394A (en) Method for the treatment of respiratory disease
GB2266241B (en) Treatment of pastures
GB9201391D0 (en) Method of treatment
HU9203841D0 (en) Method for producing preparative applicable for prevention and treatment of hoof diseases
GB9319897D0 (en) Method for the treatment and shaping of hair
GB9207595D0 (en) Treatment of pastures
ZA936136B (en) Treatment of skin diseases
HU9301856D0 (en) Application of glutarimide derivatives for treating depressive and maniacal diseases
AU3286893A (en) Therapeutic device and method of treatment
IL103663A0 (en) A device and method for the treatment of rheumatic diseases
BG95955A (en) Method for the preparation of therapeutical means of arthrosis treatment